Primary Causes & Pathophysiology
A thrombus dislodges from a systemic vein (usually deep veins of the legs or pelvis) and embolises through the right atrium and ventricle into the pulmonary arterial circulation. The physical occlusion, compounded by reflex hypoxic vasoconstriction and the local release of vasoactive mediators (such as thromboxane A2 and serotonin), abruptly increases pulmonary vascular resistance. This acute spike in right ventricular afterload causes RV dilation, septal flattening, and potentially RV ischaemia and failure (acute cor pulmonale). Concurrently, the occlusion creates alveolar dead space (areas ventilated but not perfused), leading to impaired gas exchange, hypoxaemia, and reflex hyperventilation resulting in hypocapnia.
A thrombus forming in the deep venous system of the lower extremities or pelvis (driven by Virchow's triad: stasis, endothelial injury, hypercoagulability) breaks free and travels to the pulmonary vascular bed.
Tumour cells secrete procoagulant factors (e.g., tissue factor) and induce systemic inflammation, creating a severe hypercoagulable state responsible for unprovoked thromboembolism.
Direct endothelial vessel injury, prolonged perioperative immobility causing venous stasis, and a stress-induced hypercoagulable state robustly promote clot formation.
Physiological adaptations create a hypercoagulable state (increased clotting factors, decreased protein S) which, combined with venous stasis from gravid uterine compression of the inferior vena cava, strongly predisposes to VTE.